Taxing issues for multinationals

US multinationals, which attribute income to subsidiaries in lower-tax countries such as Ireland, may be forced by the Obama administration to change their accounting practices, writes Jesse Drucker

15th May, 2010

Over the past three years, pharma giant Pfizer was an earner without profit in its own country.

The maker of cholesterol medication Lipitor - one of the world’s top-selling prescription drugs - reported almost half its revenues in the US for 2007 to 2009,while booking domestic pre-tax losses totalling $5.2 billion.

In other countries, it was a different story. A Dutch subsidiary more than made up for New York-based Pfizer’s American losses. It reported pre-tax...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Newsround: What Thursday’s papers say